Key Financials | KlickAnalytics

1.14 -0.01(-0.87%)05/20/2024
Akebia Therapeutics Inc. (AKBA)

(Values in USD Thousands)

	2024-03-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31
Net Income	-17,985	-14,489	-11,172	-16,738
Revenue	32,607	42,046	56,376	40,127
Cost Of Revenue	11,969	18,009	17,284	19,484
gross Profit	20,638	24,037	39,092	20,643
Operating Expenses	35,516	36,904	48,182	45,475
Selling General and Administrative Expenses	26,149	22,710	27,036	25,221
Research and Development Expenses	9,367	13,330	20,197	19,686
Other Expenses	95	-43	-1,652	568
Cost And Expenses	47,485	54,913	65,466	64,959
Operating Income	-14,878	-13,036	-8,996	-24,832
Income Tax Expense		1,367	94	-9,479
Income Before Tax	-17,985	-14,489	-11,172	-26,217
Earning Per Share Basic	-0.09	-0.08	-0.06	-0.09
Earning Per Share Diluted	-0.09	-0.08	-0.06	-0.09
weighted Average Shares Outstanding	204,955	188,306	186,817	184,769
weighted Average Shares Outstanding (Diluted)	204,955	188,306	186,817	184,769
Gross Margin	0.63	0.57	0.69	0.51
EBIT Margin	-0.17	-0.08	-0.15	-0.62
Profit Margin	-0.55	-0.34	-0.20	-0.42
EBITDA	-5,503	-3,503	-8,660	-24,726
Earning Before Tax Margin	-0.55	-0.34	-0.20	-0.65